The changes in MUC5AC expression in gastric cancer before and after Helicobacter pylori eradication

Clinics and Research in Hepatology and Gastroenterology

Volumn 38, Issue 2, 2014, Pages 235-240

  Shi, Ding ^a   Qiu, Xin min ^a   Yan, Xing jun ^b  

^a HANGZHOU FIRST PEOPLE'S HOSPITAL   (China)

^b YIWU CENTRAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MUCIN 5AC; MUC5AC PROTEIN, HUMAN;

ARTICLE; CANCER TISSUE; CONTROLLED STUDY; ERADICATION THERAPY; HELICOBACTER INFECTION; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; PROTEIN CONTENT; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; STOMACH CANCER; TISSUE LEVEL; WESTERN BLOTTING; ADENOCARCINOMA; ADULT; AGED; CASE CONTROL STUDY; FEMALE; GENETICS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; STOMACH TUMOR;

ADENOCARCINOMA; ADULT; AGED; BLOTTING, WESTERN; CASE-CONTROL STUDIES; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MUCIN 5AC; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; STOMACH NEOPLASMS;

EID: 84899478099     PISSN: 22107401     EISSN: 2210741X     Source Type: Journal    
DOI: 10.1016/j.clinre.2013.06.008     Document Type: Article

References (39)

1. Byrd J.C., Yunker C.K., Xu Q.S., Sternberg L.R., Bresalier R.S. Inhibition of gastric mucin synthesis by Helicobacter pylori. Gastroenterology 2000, 118:1072-1079. [5].
2. Van den Brink G.R., Tytgat K.M., Van der Hulst R.W., Van der Loos C.M., Einerhand A.W., Büller H.A., et al. H pylori colocalizes with MUC5AC in the human stomach. Gut 2000, 46:601-607.
3. Van de Bovenkamp J.H., Mahdavi J., Korteland-Van Male A.M., Büller H.A., Einerhand A.W., Borén T., et al. The MUC5AC glycoprotein is the primary receptor for Helicobacter pylori in the human stomach. Helicobacter 2003, 8:521-532.
4. Kocer B., Ulas M., Ustundag Y., Erdogan S., Karabeyoglu M., Yldrm O., et al. A confirmatory report for the close interaction of Helicobacter pylori with gastric epithelial MUC5AC expression. J Clin Gastroenterol 2004, 38:496-502.
5. Byrd J.C., Yan P., Sternberg L., Yunker C.K., Scheiman J.M., Bresalier R.S. Aberrant expression of gland-type gastric mucin in the surface epithelium of Helicobacter pylori positive patients. Gastroenterology 1997, 113:455-464.
6. Marques T., David L., Reis C., Nogueira A. Topographic expression of MUC5AC and MUC6 in the gastric mucosa infected by Helicobacter pylori and in associated diseases. Pathol Res Pract 2005, 201:665-672.
7. Kang H.M., Kim N., Park Y.S., Hwang J.H., Kim J.W., Jeong S.H., et al. Effects of Helicobacter pylori Infection on gastric mucin expression. J Clin Gastroenterol 2008, 42:29-35.
8. Ota H., Nakayama J., Momose M., Hayama M., Akamatsu T., Katsuyama T., et al. Helicobacter pylori infection produces reversible glycosylation changes to gastric mucins. Virchows Arch 1998, 433:419-426.
9. Suh Y.S., Lee H.J., Jung E.J., Kim M.A., Nam K.T., Goldenring J.R., et al. The combined expression of metaplasia biomarkers predicts the prognosis of gastric cancer. Ann Surg Oncol 2012, 19:1240-1249.
10. Ilhan Ö., Han Ü., Önal B., Çelik S.Y. Prognostic significance of MUC1, MUC2 and MUC5AC expressions in gastric cancer. Turk J Gastroenterol 2010, 21:345-352.
11. Zhang H.K., Zhang Q.M., Zhao T.H., Li Y.Y., Yi Y.F. Expression of mucins and E-cadherin in gastric cancer and their clinical significance. World J Gastroenterol 2004, 10:3044-3047.
12. Guyonnet Duperat V., Audie J.P., Debailleul V., Laine A., Buisine M.P., Galiegue-Zouitina S., et al. Characterization of the human mucin gene MUC5AC: a consensus cysteine-rich domain for 11p15 mucin genes?. Biochem J 1995, 305:211-219.
13. Reis C.A., David L., Carvalho F., Mandel U., de Bolós C., Mirgorodskaya E., et al. Immunohistochemical study of the expression of MUC6 mucin and co-expression of other secreted mucins (MUC5AC and MUC2) in human gastric cancers. J Histochem Cytochem 2000, 48:377-388.
14. Reis C.A., David L., Nielsen P.A., Clausen H., Mirgorodskaya K., Roepstorff P., et al. Immunohistochemical study of MUC5AC expression in human gastric cancers using a novel monoclonal antibody. Int J Cancer 1997, 74:112-121.
15. Babu S.D., Jayanthi V., Devaraj N., Reis C.A., Devaraj H. Expression profile of mucins (MUC2, MUC5AC and MUC6) in Helicobacter pylori infected pre-neoplastic and neoplastic human gastric epithelium. Mol Cancer 2006, 19(5):10.
16. Wang R.Q., Fang D.C. Effects of Helicobacter pylori infection on mucin expression in gastric cancer and pericancerous issues. J Gastroenterol Hepatol 2006, 21:425-431.
17. Matsuda K., Yamauchi K., Matsumoto T., Sano K., Yamaoka Y., Ota H. Quantitative analysis of the effect of Helicobacter pylori on the expressions of SOX2, CDX2, MUC2, MUC5AC, MUC6, TFF1, TFF2, and TFF3 mRNAs in human gastric cancer cells. Scand J Gastroenterol 2008, 43:25-33.
18. Chiba T., Marusawa H., Seno H., Watanabe N. Mechanism for gastric cancer development by Helicobacter pylori infection. J Gastroenterol Hepatol 2008, 23:1175-1181.
19. Polk D.B., Peek R.M. Helicobacter pylori: gastric cancer and beyond. Nat Rev Cancer 2010, 10:403-414.
20. Pinto-de-Sousa J., David L., Reis C.A., Gomes R., Silva L., Pimenta A. Mucins MUC1, MUC2, MUC5AC and MUC6 expression in the evaluation of differentiation and clinico-biological behaviour of gastric cancer. Virchows Arch 2002, 440:304-310.
21. Gomceli I., Demiriz B., Tez M. Gastric carcinogenesis. World J Gastroenterol 2012, 18:5164-5170.
22. Baldus S.E., Mönig S.P., Arkenau V., Hanisch F.G., Schneider P.M., Thiele J., et al. Correlation of MUC5AC immunoreactivity with histopathological subtypes and prognosis of gastric cancer. Ann Surg Oncol 2002, 9:887-993.
23. Pinto-de-Sousa J., Reis C.A., David L., Pimenta A., Cardoso-de-Oliveira M. MUC5B expression in gastric cancer: relationship with clinico-pathological parameters and with expression of mucins MUC1, MUC2, MUC5AC and MUC6. Virchows Arch 2004, 444:224-230.
24. Radziejewska I. The role of gastric mucins in interactions with Helicobacter pylori. Postepy Hig Med Dosw 2012, 66:60-66. [Article in Polish, online].
25. Van den Brink G.R., Tytgat K.M., Van der Hulst R.W., Van der Loos C.M., Einerhand A.W., Büller H.A., et al. H.pylori colocalises with MUC5AC in the human stomach. Gut 2000, 46:601-607.
26. Schmitz J.M., Durham C.G., Ho S.B., Lorenz R.G. Gastric mucus alterations associated with murine Helicobacter infection. J Histochem Cytochem 2009, 57:457-467.
27. Sun Y., Li J.Y., He J.S., Zhou L.X., Chen K. Tissue microarray analysis of multiple gene expression in intestinal metaplasia, dysplasia and cancer of the stomach. Histopathology 2005, 46:505-514.
28. Carrato C., Balague C., de Bolos C., Gonzalez E., Gambus G., Planas J., et al. Differential apomucin expression in normal and neoplastic human gastrointestinal tissues. Gastroenterology 1994, 107:160-172.
29. Machado J.C., Nogueira A.M., Carneiro F., Reis C.A., Sobrinho-Simões M. Gastric cancer exhibits distinct types of cell differentiation: an immunohistochemical study of trefoil peptides (TFF1 and TFF2) and mucins (MUC1, MUC2, MUC5AC, and MUC6). J Pathol 2000, 190:437-443.
30. Song J.Y., Kim B.W., Lee A.W., Lee K.Y., Chung I.S., Lee B.I., et al. Expression of MUC5AC and trefoil peptide 1 (TFF1) in the subtypes of intestinal metaplasia. Clin Endosc 2012, 45:151-154.
31. Ho S.B., Shekels L.L., Toribara N.W., Kim Y.S., Lyftogt C., Cherwitz D.L., et al. Mucin gene expression in normal, preneoplastic, and neoplastic human gastric epithelium. Cancer Res 1995, 55:2681-2690.
32. Slomiany B.L., Slomiany A. Mechanism of Helicobacter pylori pathogenesis: focus on mucus. J Clin Gastroenterol 1992, 14:S114-S121.
33. Xue L., Zhang X., Li Y., Yang H., Li X., Mi J., et al. Differences of immunophenotypic markers and signaling molecules between adenocancers of gastric cardia and distal stomach. Hum Pathol 2011, 42:594-601.
34. Tanaka S., Mizuno M., Maga T., Yoshinaga F., Tomoda J., Nasu J., et al. H.pylori decreases gastric mucin synthesis via inhibition of galactosyltransferase. Hepatogastroenterology 2003, 50:1739-1742.
35. Fichman S., Niv Y. Histological changes in the gastric mucosa after Helicobacter pylori eradication. Eur J Gastroenterol Hepatol 2004, 16:1183-1188.
36. Nomura S., Baxter T., Yamaguchi H., Leys C., Vartapetian A.B., Fox J.G., et al. Spasmolytic polypeptide expressing metaplasia to preneoplasia in H.felispositive mice. Gastroenterology 2004, 127:582-594.
37. Karasawa F., Shiota A., Goso Y., Kobayashi M., Sato Y., Masumoto J., et al. Essential role of gastric gland mucin in preventing gastric cancer in mice. J Clin Invest 2012, 122:923-934.
38. Namikawa T., Hanazaki K. Mucin phenotype of gastric cancer and clinicopathology of gastric-type differentiated adenocancer. World J Gastroenterol 2010, 16:4634-4639.
39. Jia Y., Persson C., Hou L., Zheng Z., Yeager M., Lissowska J., et al. A comprehensive analysis of common genetic variation in MUC1, MUC5AC, MUC6 genes and risk of stomach cancer. Cancer Causes Control 2010, 21:313-321.